Scientists are collecting information on the new Delta Plus Covid-19 mutation, a sublineage of the Delta variant that is causing infections to rise globally
The Covid-19 J&J and Pfizer vaccines remain effective in protecting against severe sickness and hospitalisation
SA’s lockdown regulations are tightening to better curb the spread of Covid-19, amid concerns that the Delta variant could drive a surge of infections
Scientists in South Africa say there’s no evidence that the B.1.617 is worse than our local variant
Phase two of the Covid-19 vaccine roll-out aims to commence mid-May. People eligible for this phase, including over-60s, can now register online
Health Minister Zweli Mkhize says selling on the vaccines will stem wasteful expenditure, but people close to the discussions with AU say they will be sold on the cheap
Few trials have been carried out on women expecting babies
SA’s one-million doses of the AstraZeneca vaccine will expire by early April — unless India’s Serum Institute can safely extend their use-by date.
The first batch of vaccines is almost here, but a top government adviser says achieving herd immunity by the end of the year is ‘unrealistic’
Full track and traceability of Covid-19 jabs won’t happen during South Africa’s vaccine roll-out, as the health department has not yet adopted the “overarching” system that would make this possible.
The department of health is also negotiating with manufacturers other than AstraZeneca to secure more than one type of vaccine
Rhulani Nhlaniki is Pfizer’s cluster lead for sub-Saharan Africa. As Pfizer starts phase III of the clinical trial of their Covid-19 vaccine candidate, he tells Malaikah Bophela that if it is successful, the company will ensure the vaccine will be available to everyone who needs it